GE HealthCare Technologies Inc. (GEHC) Stock Score, Valuation & Financial Research
GE HealthCare Technologies Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 37/100.
Quick answer for GEHC
GE HealthCare Technologies Inc. currently has a Wall Street Score of 37/100. The stored market price is $63.49. Its financial score is 36/100. Its valuation score is 22/100. The latest WSS change is -1.4 points. These figures are a research snapshot, not a buy or sell recommendation.
What GE HealthCare Technologies Inc. does
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health prod
GEHC financial snapshot
- Wall Street Score:
- 37/100
- Current price:
- $63.49
- Market capitalization:
- $28.68B
- Revenue:
- $20.24B
- Net income:
- $1.59B
- Free cash flow:
- $1.51B
- Cash:
- $2.10B
- Total debt:
- $10.09B
- EPS:
- 3.48
- P/E ratio:
- 18.2x
- Financial score:
- 36/100
- Valuation score:
- 22/100
- Revenue score:
- 17/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $1.51B, showing positive cash generation.
- The balance sheet shows $2.10B of cash versus $10.09B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is -1.4 points: GEHC decreased 1.4 points because Valuation declined by 8.3 points.
What the numbers mean
Its current valuation score is 22/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 36/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-04.
How to research GEHC
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.